Genedrive PLC Director/PDMR Shareholding (1214C)
06 February 2020 - 4:32AM
UK Regulatory
TIDMGDR
RNS Number : 1214C
Genedrive PLC
05 February 2020
Notification and public disclosure of transactions by persons
discharging
managerial responsibilities and persons closely associated with
them
genedrive plc (LSE: GDR) ("genedrive" or the "Company"), the
near patient molecular diagnostics company, announces that Dr Ian
Gilham, Non-Executive Chairman, acquired 125,000 ordinary shares of
1.5p each ("Ordinary Shares") today at 8p per share and Tom
Lindsay, Non-Executive Director, acquired 125,000 Ordinary Shares
today at 8p per share.
Gino Miele, R&D Director and a PDMR, acquired 27,798
Ordinary Shares in the Company at a price of 11.56p per share
yesterday and acquired 20,921 Ordinary Shares at 9.5p per share
today.
Following these purchases, Dr Ian Gilham is interested in
490.674 Ordinary Shares, 1.4% of the issued share capital of the
Company, Tom Lindsay is interested in 190,217 Ordinary Shares, 0.5%
of the issued share capital of the Company and Gino Miele is
interested in 56,719 Ordinary Shares, 0.2% of the issued share
capital of the Company.
The information set out below is provided in accordance with the
requirements of Article 19(3) of the EU Market Abuse Regulation No
596/2014.
1. Details of the person discharging managerial responsibilities
/ person closely associated
a. Name 1. Ian Gilham
2. Tom Lindsay
------------------------------ --------------------------------------------
2. Reason for the notification
----------------------------------------------------------------------------
a. Position/status 1. Non-Executive Chairman
2. Non-Executive Director
------------------------------ --------------------------------------------
a. Initial notification Initial notification
/Amendment
------------------------------ --------------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
----------------------------------------------------------------------------
a. Name genedrive plc
------------------------------ --------------------------------------------
b. LEI 213800ZYODIRZ87Y4K14
------------------------------ --------------------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
----------------------------------------------------------------------------
a. Description of Ordinary shares of 1.5 pence each
the
Financial instrument,
type
of instrument GB00B1VKB244
Identification
code
------------------------------ --------------------------------------------
b. Nature of the Purchase
transaction
------------------------------ --------------------------------------------
c. Price(s) and Price(s) Volume(s)
volume(s) 1. 8p 1. 125,000
----------------------
2. 8p 3. 125,000
----------------------
------------------------------ --------------------------------------------
d. Aggregated information
* Aggregated volume N/A
* Price
------------------------------ --------------------------------------------
e. Date of the transaction 2020-02-05
------------------------------ --------------------------------------------
f. Place of the London Stock Exchange, AIM
transaction
------------------------------ --------------------------------------------
1. Details of the person discharging managerial responsibilities
/ person closely associated
b. Name Gino Miele
------------------------------ -----------------------------------------
2. Reason for the notification
-------------------------------------------------------------------------
c. Position/status R&D Director
------------------------------ -----------------------------------------
b. Initial notification Initial notification
/Amendment
------------------------------ -----------------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------------
g. Name genedrive plc
------------------------------ -----------------------------------------
h. LEI 213800ZYODIRZ87Y4K14
------------------------------ -----------------------------------------
4. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------------
i. Description of Ordinary shares of 1.5 pence each
the
Financial instrument,
type
of instrument GB00B1VKB244
Identification
code
------------------------------ -----------------------------------------
j. Nature of the Purchase
transaction
------------------------------ -----------------------------------------
k. Price(s) and Price(s) Volume(s)
volume(s) 11.56p 27,798
------------------
------------------------------ -----------------------------------------
l. Aggregated information
* Aggregated volume N/A
* Price
------------------------------ -----------------------------------------
m. Date of the transaction 2020-02-04
------------------------------ -----------------------------------------
n. Place of the London Stock Exchange, AIM
transaction
------------------------------ -----------------------------------------
5. Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------------
a. Description of Ordinary shares of 1.5 pence each
the
Financial instrument,
type
of instrument GB00B1VKB244
Identification
code
------------------------------ -----------------------------------------
b. Nature of the Purchase
transaction
------------------------------ -----------------------------------------
c. Price(s) and Price(s) Volume(s)
volume(s) 9.5p 20,921
------------------
------------------------------ -----------------------------------------
d. Aggregated information
* Aggregated volume N/A
* Price
------------------------------ -----------------------------------------
e. Date of the transaction 2020-02-05
------------------------------ -----------------------------------------
f. Place of the London Stock Exchange, AIM
transaction
------------------------------ -----------------------------------------
For further details please contact:
genedrive plc +44 (0)161 989 0245
David Budd: CEO / Matthew Fowler:
CFO
Peel Hunt LLP (Nominated Adviser and
Joint Broker) +44 (0)20 7418 8900
James Steel / Oliver Jackson
Stanford Capital Partners Limited
(Joint Broker) +44 (0)20 3815 8880
Patrick Claridge / John Howes
Walbrook PR Ltd (Media Relations & +44 (0)20 7933 8780 or genedrive@walbrookpr.com
Investor Relations)
+44 (0)7980 541 893 / +44 (0)7876
Paul McManus / Anna Dunphy 741 001
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHEAXASEDEEEFA
(END) Dow Jones Newswires
February 05, 2020 12:32 ET (17:32 GMT)
Genedrive (LSE:GDR)
Historical Stock Chart
From Apr 2024 to May 2024
Genedrive (LSE:GDR)
Historical Stock Chart
From May 2023 to May 2024
